分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Hepatic GAPDH prevents excessive fasting-induced steatosis via serine-dependent inhibition of diacylglycerol synthesis

Zhou Yihao, Yuan Yan, Xie Yunhao, Shi Jiajian, Song Hejun, Liu Yuxia, Wang Jiao, Fan Pei, Cui Tongcan, Chen Hong, Zhao Xiaolu, Liu Xinran, Huang Kun, Zheng Ling

Journal:CELL DEATH AND DIFFERENTIATION

IF:13.6

DOI:10.1038/s41418-026-01706-9

PMID:

Published:2026-03-17

research field:分子生物学肝脏病学代谢学营养生物化学

Abstract

Fasting-induced metabolic remodeling is a fundamental process maintaining systemic homeostasis, with profound implications for metabolic disease interventions. During fasting, liver establishes a regulatory network centered on gluconeogenesis that integrates major fuels to keep physiological energy homeostasis. Here, we report that GAPDH, a key enzyme in both glycolysis and gluconeogenesis, senses fasting stress in the liver. Compared to wildtype controls, hepatocyte Gapdh deficiency ( Gap Alb ) mice show comparable blood glucose, decreased amino acid levels and aggravated lipid accumulation in the liver after overnight fasting. Mechanistically, Gapdh depletion decreases serine levels, and serine supplementation inhibits PA-DAG (phosphatidic acid-diacylglycerols) axis by downregulating Lipin1 (a phosphohydrolase in DAG synthesis) upon overnight fasting. Furthermore, knockdown of Lipin1 rescued the effects observed in fasted Gap Alb mice. Similarly, Gap Alb mice showed enhanced hepatic lipid accumulation under ketogenic diets, and serine supplementation abolished these effects. Together, we find hepatic GAPDH as a central hub in glucose-amino acid-fat metabolism during nutritional limitation.

本文使用的Yeasen产品

购物车
客服
转染试用